ICUI - ICU Medical, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
221.79
-3.53 (-1.57%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close225.32
Open226.49
Bid221.79 x 1300
Ask222.01 x 800
Day's Range219.13 - 229.09
52 Week Range210.94 - 321.70
Volume279,937
Avg. Volume172,908
Market Cap4.568B
Beta (3Y Monthly)0.70
PE Ratio (TTM)166.76
EPS (TTM)1.33
Earnings DateMay 7, 2019 - May 13, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est290.00
Trade prices are not sourced from all markets
  • GlobeNewswireyesterday

    ICU Medical, Inc. Announces Time of First Quarter 2019 Earnings Conference Call

    SAN CLEMENTE, Calif., April 18, 2019 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion.

  • Need To Know: ICU Medical, Inc. (NASDAQ:ICUI) Insiders Have Been Selling Shares
    Simply Wall St.8 days ago

    Need To Know: ICU Medical, Inc. (NASDAQ:ICUI) Insiders Have Been Selling Shares

    We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is that there are more than a few examples of insiders dumping stock prior to a period of weak performance. So before you...

  • Markit10 days ago

    See what the IHS Markit Score report has to say about ICU Medical Inc.

    ICU Medical Inc NASDAQ/NGS:ICUIView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is low for ICUI with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding ICUI are favorable with net inflows of $72.41 billion. This was the highest net inflow seen over the last one-year.Error parsing the SmartText Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Baxter (BAX) Soars to 52-Week High, Time to Cash Out?
    Zacks28 days ago

    Baxter (BAX) Soars to 52-Week High, Time to Cash Out?

    Baxter (BAX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

  • Reuters28 days ago

    Smiths plans to list medical unit, focus on industrial technology

    The healthcare business has suffered from product delays, stricter European regulations and two lost contracts in the United States. A plan to merge it with U.S.-based ICU Medical fell through in September because Smiths and ICU could not agree on terms. "Pursuing a demerger of Smiths Medical will lead to two stronger companies, each...maximising the opportunities in their respective markets," Chief Executive Andy Reynolds Smith said.

  • Looking for a Growth Stock? 3 Reasons Why ICU Medical (ICUI) is a Solid Choice
    Zackslast month

    Looking for a Growth Stock? 3 Reasons Why ICU Medical (ICUI) is a Solid Choice

    ICU Medical (ICUI) is well positioned to outperform the market, as it exhibits above-average growth in financials.

  • Thomson Reuters StreetEventslast month

    Edited Transcript of ICUI earnings conference call or presentation 28-Feb-19 9:30pm GMT

    Q4 2018 ICU Medical Inc Earnings Call

  • GuruFocus.com2 months ago

    ICU Medical Inc (ICUI) Files 10-K for the Fiscal Year Ended on December 31, 2018

    ICU Medical Inc is engaged in the development, manufacture and sale of medical devices used in infusion therapy, oncology and critical care applications. ICU Medical Inc had annual average EBITDA growth of 7.50% over the past ten years. GuruFocus rated ICU Medical Inc the business predictability rank of 2.5-star.

  • GlobeNewswire2 months ago

    ICU Medical, Inc. to Present at the Raymond James 40th Annual Institutional Investors Conference

    SAN CLEMENTE, Calif., March 01, 2019 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion.

  • ICU Medical Inc (ICUI) Q4 2018 Earnings Conference Call Transcript
    Motley Fool2 months ago

    ICU Medical Inc (ICUI) Q4 2018 Earnings Conference Call Transcript

    ICUI earnings call for the period ending December 31, 2018.

  • GlobeNewswire2 months ago

    ICU Medical, Inc. Announces Fourth Quarter 2018 Results

    SAN CLEMENTE, Calif., Feb. 28, 2019 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy.

  • Reuters2 months ago

    U.S. closes IV solution shortage antitrust probe, Baxter says

    Baxter International Inc said the U.S. Justice Department has closed an antitrust probe examining possible communication among producers of intravenous saline solutions during supply shortages that created higher prices. Baxter, which received a grand jury subpoena in 2017 as part of the investigation, said in a filing with the U.S. Securities and Exchange Commission on Thursday that the department informed it on Nov. 30 of its decision to end the probe. Other companies that in April 2017 disclosed receiving subpoenas as part of the investigation included Pfizer Inc and ICU Medical Inc, which earlier that year had acquired Pfizer's global infusion therapy business.

  • Analysts Estimate ICU Medical (ICUI) to Report a Decline in Earnings: What to Look Out for
    Zacks2 months ago

    Analysts Estimate ICU Medical (ICUI) to Report a Decline in Earnings: What to Look Out for

    ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • GlobeNewswire2 months ago

    Recent Analysis Shows Corcept Therapeutics, CDK Global, Dynavax Technologies, ICU Medical, American Vanguard, and Cabot Market Influences — Renewed Outlook, Key Drivers of Growth

    NEW YORK, Feb. 11, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

  • GlobeNewswire2 months ago

    ICU Medical, Inc. Announces Time of Fourth Quarter and Fiscal Year 2018 Earnings Conference Call

    SAN CLEMENTE, Calif., Feb. 07, 2019 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion.

  • Looking At ICU Medical, Inc. (NASDAQ:ICUI) From All Angles
    Simply Wall St.2 months ago

    Looking At ICU Medical, Inc. (NASDAQ:ICUI) From All Angles

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Building up an investment case requires looking Read More...

  • Are ICU Medical, Inc.’s (NASDAQ:ICUI) High Returns Really That Great?
    Simply Wall St.3 months ago

    Are ICU Medical, Inc.’s (NASDAQ:ICUI) High Returns Really That Great?

    Today we are going to look at ICU Medical, Inc. (NASDAQ:ICUI) to see whether it might be an attractive investment prospect. Specifically, we're going to calculate its Return On Capital Read More...

  • GlobeNewswire4 months ago

    ICU Medical, Inc. to Present at the 37th J.P. Morgan Healthcare Conference

    SAN CLEMENTE, Calif., Dec. 27, 2018 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion.

  • Calculating The Fair Value Of ICU Medical, Inc. (NASDAQ:ICUI)
    Simply Wall St.4 months ago

    Calculating The Fair Value Of ICU Medical, Inc. (NASDAQ:ICUI)

    How far off is ICU Medical, Inc. (NASDAQ:ICUI) from its intrinsic value? Using the most recent financial data, I am going to take a look at whether the stock is Read More...

  • Biotech markets could be ‘very promising’ in 2019
    Yahoo Finance Video4 months ago

    Biotech markets could be ‘very promising’ in 2019

    Even though biotech markets are “down big this year,” Managing Director Mitchell Ng of Thessalus Capital says that there are “specific industries within the healthcare sector that are very promising,” such as gene editing companies. Yahoo Finance’s Alexis Christoforous speaks to him about the future for biotech in 2019.